I don't think a takeover is imminent, certainly a partnership is possible in the near term. There could be another capital raise to fund the vitiligo trials, not sure how much money that would require and whether Clinuvel could fund it on a rolling basis as revenue streams in.
I don't think PW would sell out at anytime in the near future, he has been in this game for far too long to just give in on the cusp of greatness for Clinuvel. I think the recent share price hike from $5.20 to $6.40 or thereabouts proved that rises such as these can be sustained, I'm deeply hoping there won't be a severe pullback as profit taking occurs. My take: another surge will happen on Monday regardless of whether the report is released in the morning or afternoon, be it from new interest generated from the phenomenal hike or lack of available shares. The report will further this surge but their could be a pullback later in the week. However I think the stock will remain permanently above $10.
Incredible to think that we will be at $10 whereas I was certain this figure wasn't going to appear until the middle of next year. This stock is starting to take on a price boom characteristic that can occur with other pharmaceutical stocks, for example a nascent pharma with a Phase 2 cancer drug where stakeholders bet on future prospects well before time. However, the difference with Clinuvel is that it is a bona fide company with revenue and possible first profit coming soon. Given this solid foundation that Clinuvel has, stakeholders could accumulate and new investors could drive the price well ahead to a level that is not commensurate to Clinuvel's fundamentals.
I do hope this occurs quickly though, but at the same time it makes for a nervous experience. Will have to rely on Kenny Rogers' advice from 'The Gambler"...
